Optimal dose of lactoferrin reduces the resilience of in vitro staphylococcus aureus colonies

HIGHLIGHTS

• who: Jagir R. Hussan and collaborators from the Auckland Bioengineering Institute, University of Auckland, Auckland, NZ, Department of Molecular have published the research work: Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies, in the Journal: PLOS ONE of August/12,/2022
• what: With the aid of a mathematical model the authors show that lactoferrin stratifies the bacterial population and the resulting population heterogeneity is at the basis of the dose dependent response seen. The analysis shows that an optimal dose of lactoferrin acts as a suitable adjuvant to eliminate S . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.